NATALIE MILLS: Open Payments
NPI 1568912327 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$617 in 20 payments from 9 companies in 2025. Trend: 2023 $554 · 2024 $481 · 2025 $617
Food & beverage: $517Education: $100
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $236 |
| Janssen Biotech, Inc. | 6 | $213 |
| ABBVIE INC. | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $31 |
| Galderma Laboratories, L.P. | 1 | $25 |
| Organon LLC | 1 | $20 |
| Incyte Corporation | 1 | $19 |
| Lilly USA, LLC | 1 | $17 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
Products named: TREMFYA, Rhapsido, COSENTYX, NEMLUVIO, RINVOQ, OPZELURA, SKYRIZI, EBGLYSS.
Industry payments across NM — which companies pay providers there.
